“…Various scoring systems have been proposed to identify indicators for development of RP-ILD in anti-MDA5 patients in cohorts of patients with acute and chronic ILD [ 4 , 5 ]. However, asymptomatic or slowly progressive cases of anti-MDA5 ILD are not well described in the literature [ 6 ]. We report three cases of Latino patients with asymptomatic or slowly progressive anti-MDA5 ILD ( Table 1 , Fig.…”